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Results: Preliminary data show that the medial and lateral tibial plateaus
had signiﬁcant difference in subchondral bone parameters especially at
24 week of age. The medial plateaus showed an increase in BMD up
to 30 weeks and increases in SbpTh and trabecular thickness (TbTh)
up to week 24. These parameters were signiﬁcantly higher in the
medial compared to the lateral site (BMD, P< 0.05; SbpTh, P < 0.001;
TbTh, P < 0.05). The lateral plateau, showed a signiﬁcant increase in
bone volume/tissue volume (BV/TV) (P < 0.05), trabecular bone number
(TbN) (P < 0.01) and a signiﬁcant decrease in trabecular bone pattern
factor (TbPf) (P < 0.001) between 16 and 24 weeks. Of all the bone
parameters, only TbN (P < 0.05) was signiﬁcantly higher in the lateral
plateau while trabecular bone separation (TbSp) was signiﬁcantly lower
(P < 0.001), compared to the medial plateau. Macroscopic scores did not
show any signiﬁcant changes over the study period. But, microscopic
grading showed mild to moderate cartilage damage which was higher
in the medial than the lateral plateaus. There were some association
between the severity of cartilage degeneration and subchondral bone
changes tibial plateau.
Conclusions: Our preliminary data showing a signiﬁcant increase in
subchondral bone plate thickness in the medial compared to the lateral
plateau support the theory that subchondral bone plate thickness in
the medial site precedes changes in the lateral site in early OA.
The subchondral plate thickening may be viewed as an attempt to
compensate over compromised structural trabecular parameters and
hence preserve mechanical properties, while the thicker trabecular bone
may strengthen and compensate for the lack of connectivity found in
the medial as compared to the lateral plateau.
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THE DIFFERENTIATION OF CARTILAGE CHANGES AFTER ANTERIOR
CRUCIATE LIGAMENT TRANSECTION AMONG RABBITS OF DISTINCT
AGES
Q. Jiang, M. Chu, L. Sun, D. Shi. Ctr. of Diagnosis and Treatment for joint
disease, Nanjing, China
Purpose: In order to understand more about anterior cruciate ligament
(ACL) injury and help dealing with ACL injury patients of different ages,
we studied cartilage changes after ACL transection among rabbits of
distinct ages.
Methods: In total, 30 rabbits comprising 3 age groups (A: 6 months,
B: 12 months, C: 24 months, n = 10) were used for analysis. Each group
was randomly divided into 5 groups (n =2). Rabbits’ right knees received
ACL transaction, and the left knees were treated as control. Rabbits were
sacriﬁced at the time of 5, 10, 15, 20 and 25 weeks after operation. We
performed histological study (masson staining) for both knees of each
rabbit and measured cartilage water ratio (WR) and gross injury score.
Results: We found that cartilage of the right knees degenerated more
seriously than that of the left knees, and the cartilage of right knees
degenerated fastest in group B while slowest in group C by macroscopic
observation and masson staining. At 25 weeks after ACL transection,
the cartilage degeneration was slightest in the rabbits of group C, more
serious in group A, most serious in group B (Figure 1). There was a
trend that the cartilage WR was increased and then decreased with the
development of cartilage degeneration.
Conclusions: The signiﬁcant different cartilage changes among distinct
age groups suggest that the early intervention is necessary when dealing
with young and middlescent ACL injury patients, but for old patients we
may choose conservative treatment.
Fig. 1. Masson staining, 25 weeks after operation. (a) Group A;
(b) Group B; (c) Group C.
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SIMULTANEOUS TARGETING OF IL-1A AND IL-1B BY A DUAL-VARIABLE-
DOMAIN IMMUNOGLOBULIN (DVD-IG™) PREVENTS CARTILAGE
DEGRADATION IN PRECLINICAL MODELS OF OSTEOARTHRITIS
R.V. Kamath, M. Hart, D. Conlon, T. Ghayur. Abbott Labs, Worcester, MA,
USA
Purpose: Interleukin-1 (IL-1) plays a major role in the development
and progression of osteoarthritis (OA). IL-1a and IL-1b are two distinct
cytokines that bind to the same receptor and are expressed in synovial
membranes, cartilage, and synovial ﬂuid of patients with OA. IL-1 induces
structural changes (cartilage degradation, bone sclerosis & synovial
proliferation) by inducing proteases and proinﬂammatory cytokines from
all tissues (cartilage, bone and synovium) of the joint. The purpose of
the study is to demonstrate a) blockade of both IL-1a and IL-1b with
a combination of anti-mouse IL-1a and IL-1b monocloncal antibodies
(mAbs) is efﬁcacious compared to treatment with single mAbs in mouse
models of OA, and b) to demonstrate that anti-IL-1a/b dual variable
domain-Ig (DVD-Ig) produces similar efﬁcacy as the combination of
anti-mouse IL-1a and IL-1b mAbs.
Methods: Interleukin-1 (IL-1) plays a major role in the development
and progression of osteoarthritis (OA). IL-1a and IL-1b are two distinct
cytokines that bind to the same receptor and are expressed in synovial
membranes, cartilage, and synovial ﬂuid of patients with OA. IL-1 induces
structural changes (cartilage degradation, bone sclerosis & synovial
proliferation) by inducing proteases and proinﬂammatory cytokines from
all tissues (cartilage, bone and synovium) of the joint. The purpose of
the study is to demonstrate a) blockade of both IL-1a and IL-1b with
a combination of anti-mouse IL-1a and IL-1b monocloncal antibodies
(mAbs) is efﬁcacious compared to treatment with single mAbs in mouse
models of OA, and b) to demonstrate that anti-IL-1a/b dual variable
domain-Ig (DVD-Ig) produces similar efﬁcacy as the combination of
anti-mouse IL-1a and IL-1b mAbs.
Results: In both JIM and DMM model, cartilage degeneration in animals
treated with either anti-IL-1a (6mg/kg) or IL-1b mAbs (6mg/kg) was
similar to vehicle control knees. However, a combination therapy
with both antibodies (6mg/kg each signiﬁcantly decreased cartilage
degeneration scores. We have recently reported on a novel dual-
speciﬁc biologics approach, termed DVD-Ig™ that can convert two pre-
existing mAbs into a dual targeting agent by combining the variable
domains of two mAbs via naturally occurring linkers. Anti-mIL-1a/b
DVD-Ig (6mg/kg) also signiﬁcantly inhibited the progression of OA with
comparable efﬁcacy to the combination of the parental mAbs.
Conclusions: Our preclinical data demonstrate that combination of
mouse anti-mouse-IL-1a and anti-mouse-IL-1b mAb as well as anti-
mouse-IL-1a/b DVD-Ig™ molecules had signiﬁcant beneﬁcial effects on
histopathological parameters of mouse OA. These preclinical proof of
concept studies with anti-IL-1a/b DVD-Ig™ molecules form the basis
for further investigation of therapeutic IL-1a/b DVD-Ig™ molecules in
human OA patients.
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THE TYPE III COLLAGEN TURNOVER AND NITROSYLATION IN A RAT
MODEL OF COLLAGEN INDUCED ARTHRITIS (CIA). APPLYING THREE
NOVEL ELISA’S MEASURING TYPE III COLLAGEN NEOEPITOPES
A.S. Gottrup1, J. Wang2, Q. Liu2, Q. Zheng2, P. Qvist1, M.A. Karsdal1,
A-C. Bay-Jensen1. 1Nordic BioSci. A/S, Herlev, Denmark; 2Nordic BioSci.
China, Beijing, China
Purpose: The chronic inﬂammatory disease, rheumatoid arthritis,
primarily affects the synovial joints. Thickening of the synovial
membrane is the main consequences of the inﬂammation, but alterations
are also detected in cartilage and bone. During inﬂammation, nitric oxide
levels are elevated resulting in increased post-translational modiﬁcation
of extracellular proteins, such as nitrosylation of tyrosines. Thickening
of the synovial membrane, which is caused by increased cell numbers,
lead to elevated levels of proteolytic enzymes. This lead to increased
degradation of the surrounding tissue, increasing the turnover of
extracellular matrix, e.g. type III collagen. In this experiment we
investigated whether nitrosylation of tyrosine of the synovial membrane
is dependent of the turnover of the tissue (detected as type III collagen
turnover).
Methods: Collagen induced arthritis (CIA) was induced in 10 Wistar rats
by immunizations with 450ml 2mg/ml porcine type II collagen dissolved
in 0.05M acetic acid and emulsiﬁed 1:1 in Incomplete Freunds Adjuvant
